Editor-in-Chief
Charis Eng
About the journal
HMG is committed to the communication of high quality studies related to human molecular genetic disease mechanisms from the analysis of mutated genes and disease susceptibility through to therapeutics.
Find out more
Aims and Scope
Human Molecular Genetics is committed to the communication of high quality studies related to human molecular genetic disease mechanisms from the analysis of mutated genes and disease susceptibility through to therapeutics.
High-Impact Research Collection
Explore a collection of freely available high-impact research from 2020 and 2021 published in Human Molecular Genetics.
Browse the collection here
Review Issues
HMG publishes 1-2 special Review Issues each year. These topical articles are typically invited and showcase the latest in genetic innovation. Explore this repository of all published Review Issues.
Farewell and Welcome
In 2021, Human Molecular Genetics will say goodbye and thank you to Executive Editor-in-Chief Dr Anthony Wynshaw-Boris and welcome Dr Charis Eng, who will lead Human Molecular Genetics as Executive Editor in the coming years.
Email alerts
Register to receive table of contents email alerts as soon as new issues of Human Molecular Genetics are published online.
Open Access options
HMG provides open access options for authors. Find out more about publishing open access research with Human Molecular Genetics.
Committee on Publication Ethics (COPE)
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE)
